The Role of the MAPK Signaling Pathway in Cardiovascular Disease: Pathophysiological Mechanisms and Clinical Therapy

Area of Science:

• Molecular Biology
• Cardiovascular Medicine
• Cell Signaling

Background:

• Cardiovascular disease (CVD) remains a leading global cause of mortality.
• Understanding molecular pathways like MAPK signaling is vital for advancing CVD research.
• Existing knowledge on MAPK's role in CVD pathogenesis requires comprehensive summarization.

Purpose of the Study:

• To comprehensively review recent research (past five years) on the MAPK signaling pathway in cardiovascular disease.
• To focus on the role of MAPK in heart failure, atherosclerosis, myocardial ischemia-reperfusion injury, and cardiac hypertrophy.
• To elucidate pathophysiological mechanisms and propose novel clinical treatment strategies for CVD.

Main Methods:

• Extensive literature review of scientific publications.
• Analysis of research focusing on the MAPK signaling pathway.
• Synthesis of findings related to specific cardiovascular conditions and MAPK mechanisms.

Main Results:

• The MAPK signaling pathway is significantly implicated in the pathogenesis of major cardiovascular diseases.
• Specific MAPK pathways are associated with heart failure, atherosclerosis, ischemia-reperfusion injury, and cardiac hypertrophy.
• Detailed understanding of MAPK's role provides a foundation for therapeutic interventions.

Conclusions:

• The MAPK signaling pathway is a critical target for understanding and treating cardiovascular diseases.
• Further research into MAPK mechanisms can lead to the development of innovative clinical strategies for CVD.
• This review consolidates current knowledge, highlighting the importance of MAPK in cardiovascular health and disease.